SCHEMBL6877545

SCHEMBL6877545

CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)Nc3cccc([N+](=O)[O-])c3)CC2)nc2c1CCCC2

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.56
RAB9A P51151 2/20 0.56
ADRA2A P08913 1/20 0.53
MCHR1 Q99705 1/20 0.53
EPHX2 P34913 1/20 0.47
BAZ1A Q9NRL2 1/20 0.46
KMT2A Q03164 4/20 0.43
MEN1 O00255 3/20 0.43
POLB P06746 2/20 0.43
DDX3X O00571 2/20 0.43
MAPT P10636 1/20 0.43
HTT P42858 1/20 0.43
CTDSP1 Q9GZU7 1/20 0.43
CTSL P07711 1/20 0.43
CTSB P07858 1/20 0.43
CTSS P25774 1/20 0.43
CTSK P43235 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
CCNA2 P20248 1/20 0.42
CDK2 P24941 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6877551 1.00 NPC1 (0.56) NPC1RAB9AADRA2AMCHR1EPHX2
SCHEMBL6875822 0.91 PKM (0.54) NPC1RAB9AADRA2AMCHR1KMT2A
SCHEMBL6875814 0.91 PKM (0.54) NPC1RAB9AADRA2AMCHR1KMT2A
SCHEMBL7109737 0.87 NPC1 (0.54) NPC1RAB9AADRA2AMCHR1EPHX2
SCHEMBL7109740 0.87 NPC1 (0.54) NPC1RAB9AADRA2AMCHR1EPHX2
SCHEMBL6867680 0.86 ADRA2A (0.47) NPC1RAB9AADRA2AMCHR1KMT2A
SCHEMBL6873000 0.86 MCHR1 (0.47) NPC1RAB9AADRA2AMCHR1KMT2A
SCHEMBL6873005 0.86 MCHR1 (0.47) NPC1RAB9AADRA2AMCHR1KMT2A
SCHEMBL6875402 0.86 KMT2A (0.46) NPC1RAB9AADRA2AMCHR1EPHX2
SCHEMBL6875405 0.86 KMT2A (0.46) NPC1RAB9AADRA2AMCHR1EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1464335-A2 Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist Taisho Pharmaceutical Co. Ltd. (JP) 2004-10-06 EP disclosed